BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25565673)

  • 21. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
    Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
    Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy.
    Lovrić M; Božina N; Hajnšek S; Kuzman MR; Sporiš D; Lalić Z; Božina T; Granić P
    Ther Drug Monit; 2012 Oct; 34(5):518-25. PubMed ID: 22972536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
    Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics.
    Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Abdi AM; Cariti G; Di Perri G; D'Avolio A
    Int J Antimicrob Agents; 2015 Jun; 45(6):657-61. PubMed ID: 25836019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of confounding factors on a phospho-flow assay of ribosomal S6 protein for therapeutic drug monitoring of the mTOR-inhibitor everolimus in heart transplanted patients.
    Dieterlen MT; John K; Haase S; Garbade J; Tarnok A; Mohr FW; Bittner HB; Barten MJ
    Biomarkers; 2017 Feb; 22(1):86-92. PubMed ID: 27448205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy.
    Chang H; Rha SY; Jeung HC; Im CK; Noh SH; Kim JJ; Chung HC
    Oncol Rep; 2010 Jan; 23(1):271-8. PubMed ID: 19956892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
    Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
    Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters.
    Tron C; Allard M; Petitcollin A; Ferrand-Sorre MJ; Verdier MC; Querzerho-Raguideau J; Blanchet B; Le Priol J; Roussel M; Deugnier Y; Bellissant E; Lemaitre F
    Fundam Clin Pharmacol; 2019 Feb; 33(1):113-121. PubMed ID: 30203853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers.
    Kim KA; Joo HJ; Lee HM; Park JY
    Pharmacogenet Genomics; 2014 Jan; 24(1):35-42. PubMed ID: 24240480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells.
    Lemaitre F; Blanchet B; Latournerie M; Antignac M; Houssel-Debry P; Verdier MC; Dermu M; Camus C; Le Priol J; Roussel M; Zheng Y; Fillatre P; Curis E; Bellissant E; Boudjema K; Fernandez C
    Clin Biochem; 2015 Apr; 48(6):406-11. PubMed ID: 25562187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.
    Santoro A; Felipe CR; Tedesco-Silva H; Medina-Pestana JO; Struchiner CJ; Ojopi EB; Suarez-Kurtz G
    Pharmacogenomics; 2011 Sep; 12(9):1293-303. PubMed ID: 21806386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a polymorphism in the ABCB1 gene with Parkinson's disease.
    Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
    Parkinsonism Relat Disord; 2009 Jul; 15(6):422-4. PubMed ID: 19196542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
    Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
    Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of a CYP2C9 phenotyping agent, losartan, is not influenced by the common 3435C > T variation of the drug transporter gene ABCB1 (MDR1).
    Yasar U; Babaoglu MO; Bozkurt A
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):176-9. PubMed ID: 18816302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity.
    Hoerning A; Wilde B; Wang J; Tebbe B; Jing L; Wang X; Jian F; Zhu J; Dolff S; Kribben A; Hoyer PF; Witzke O
    Transplantation; 2015 Jan; 99(1):210-9. PubMed ID: 25099702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506).
    Chen YW; Smith ML; Sheets MP; Ballaron SJ; Trevillyan JM; Fey TA; Gauvin DM; Kolano R; Pong MS; Hsieh GC; Bauch J; Marsh K; Carter G; Luly J; Djuric S; Mollison KW
    Clin Immunol; 1999 Jan; 90(1):133-40. PubMed ID: 9884362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.
    Bilbao I; Salcedo M; Gómez MA; Jimenez C; Castroagudín J; Fabregat J; Almohalla C; Herrero I; Cuervas-Mons V; Otero A; Rubín A; Miras M; Rodrigo J; Serrano T; Crespo G; De la Mata M; Bustamante J; Gonzalez-Dieguez ML; Moreno A; Narvaez I; Guilera M;
    Liver Transpl; 2015 Aug; 21(8):1056-65. PubMed ID: 25990257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis.
    Naito T; Mino Y; Aoki Y; Hirano K; Shimoyama K; Ogawa N; Kagawa Y; Kawakami J
    Clin Chim Acta; 2015 May; 445():79-84. PubMed ID: 25817604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.